recent publications

• academic article

  • Choi, C. I., Kim, M. J., Jang, C. G., Park, Y. S., Bae, J. W., Lee, S. Y. Effects of the cyp2c9*1/*13 genotype on the pharmacokinetics of lornoxicam Basic & Clinical Pharmacology & Toxicology  2011 109:476-480  DOI:10.1111/j.1742-7843.2011.00751.x  PMID:21726410
  • Bae, J. W., Kim, J. H., Choi, C. I., Kim, M. J., Kim, H. J., Byun, S. A., Chang, Y. S., Jang, C. G., Park, Y. S., Lee, S. Y. Effect of cyp2c9*3 allele on the pharmacokinetics of naproxen in korean subjects Archives of Pharmacal Research  2009 32:269-273  DOI:10.1007/s12272-009-1232-z  PMID:19280158
  • Myung, C. S., Bae, J. W., Park, Y. S., Kim, M. J., Choi, C. I., Song, Y., Sa, J. H., Jang, C. G., Lee, S. Y. Analytical HPLC method validation of amiloride and its pharmacokinetic study in humans Journal of Liquid Chromatography & Related Technologies  2008 31:2455-2466  DOI:10.1080/10826070802319693
  • Bae, J. W., Kim, M. J., Park, Y. S., Myung, C. S., Jang, C. G., Lee, S. Y. Considerable interindividual variation in the pharmacokinetics of tolperisone hcl International Journal of Clinical Pharmacology and Therapeutics  2007 45:110-113  PMID:17323790
  • Bae, J. W., Park, Y. S., Sohn, U. D., Myung, C. S., Ryu, B. K., Jang, C. G., Lee, S. Y. Hplc determination of tolperisone in human plasma Archives of Pharmacal Research  2006 29:339-342  DOI:10.1007/bf02968581  PMID:16681042
  • Bae, J. W., Kim, H. K., Kim, J. H., Yang, S. I., Kim, M. J., Jang, C. G., Park, Y. S., Lee, S. Y. Allele and genotype frequencies of cyp2c9 in a korean population British Journal of Clinical Pharmacology  2005 60:418-422  DOI:10.1111/j.1365-2125.2005.02448.x  PMID:16187974  PMCID:PMC1884827
  • Briese, T., Schneemann, A., Lewis, A. J., Park, Y. S., Kim, S., Ludwig, H., Lipkin, W. I. Genomic organization of borna-disease virus Proceedings of the National Academy of Sciences of the United States of America  1994 91:4362-4366  DOI:10.1073/pnas.91.10.4362  PMID:8183914